METHODS: Retrospective study.
METHODS: Tertiary care pediatric center.
METHODS: Eligible participants were patients 8 years or older, with a history of 2 prior tubes placement. Group 1-patients completed pre-and post-Eustachian Tube Dysfunction Quality of Life Survey (ETDQ-7) survey scores, Group 2-patients had available pre- and postdilation tympanogram data (TD), and Group 3-patients had both ETDQ-7 survey and TD. The average time for the first and subsequent follow-ups was 3.8 and 12.9 months, respectively.
RESULTS: A total of 43 patients (85 ears) underwent BDET. The mean age was 13.3 years (8-18 years). Twenty-four patients were male (55.8%) and over 80% were Caucasian. The average mean ETDQ-7 score before and after dilation was 3.9 and 2.5, respectively. Ninety-three percent experienced improvement of their postoperative ETDQ-7 scores and 53% had normal postdilation ETDQ-7 score (P < .0001). Thirty-seven ears in Group 2 (60.7%) had improvement in postdilation TD. A greater proportion of ears showed improvement of 62.3% with a 95% confidence interval (CI) [50.1%-74.5%] compared to 37.7% without improvement, 95% CI [25.5%-49.87%]. Ears with type A or B TD were more likely to show improvement than ears with type C, perforated, or with tubes (P < .0001). Eighteen out of 30 ears in Group 3 (60%) experienced an improvement in both ETDQ-7 and tympanogram.
CONCLUSIONS: BDET is a safe, efficacious alternative to tubes in selected pediatric patients.
方法:回顾性研究。
方法:三级护理儿科中心。
方法:符合条件的参与者是8岁或以上的患者,具有2个先前的管放置的历史。第1组患者完成咽鼓管功能障碍前后生活质量调查(ETDQ-7)调查评分,第2组患者有可用的扩张前后鼓室图数据(TD),第3组患者进行了ETDQ-7调查和TD。第一次及以后的平均随访时间分别为3.8个月和12.9个月,分别。
结果:共有43例(85耳)患者接受了BDET。平均年龄为13.3岁(8-18岁)。24例患者为男性(55.8%),超过80%为白种人。扩张前后平均ETDQ-7评分分别为3.9和2.5。93%的患者术后ETDQ-7评分有所改善,53%的患者术后ETDQ-7评分正常(P<0.0001)。第2组中的37只耳朵(60.7%)在扩张后TD方面有所改善。与没有改善的37.7%相比,耳朵的比例更高,改善了62.3%,置信区间(CI)为95%[50.1%-74.5%]。95%CI[25.5%-49.87%]。A型或B型TD的耳朵比C型耳朵更有可能表现出改善,穿孔,或管(P<0.0001)。第3组的30只耳朵中有18只(60%)的ETDQ-7和鼓室图都有所改善。
结论:BDET是一种安全的,在选定的儿科患者中有效替代管。